top of page

Insights and News Curated for Life Science Experts by Life Science Experts....

Go back to...
JMG Logo transparent.png
Executive Spotlights

Beacon Therapeutics Appoints Dr. Lance Baldo as CEO

  • Jul 31, 2024
  • 1 min read

London and Cambridge, MA, July 24, 2024 (PRNewswire) -- Beacon Therapeutics has appointed Dr. Lance Baldo as CEO and Thomas Biancardi as CFO. Dr. Baldo has extensive biopharmaceutical experience, including roles at Genentech and Freenome. Biancardi will start his role as CFO on August 1, 2024.


Read full article here.

 
 
 

Recent Posts

See All
Qlaris Bio Appoints Fred Guerard as CEO

Dedham, MA, March 1, 2026 (Business Wire) -- Qlaris Bio has appointed Fred Guerard, Pharm.D., as president and chief executive officer, effective March 1, 2026, and he will also join the company’s b

 
 
 

Comments


Life Science Headlines
bottom of page